search
English
Bewerken
search
EN
Medewerkers
Organogram
Prof. dr. H.G.M. (Bert) Leufkens
Emeritus
Bètawetenschappen
Farmaceutische wetenschappen
Pharmacoepi. and Clinical Pharmacol.
Pharmacoepi. and Clinical Pharmacol.
h.g.m.leufkens@uu.nl
David de Wiedgebouw
Universiteitsweg 99
3584 CG Utrecht
Prof. dr. H.G.M. (Bert) Leufkens
Emeritus
Pharmacoepi. and Clinical Pharmacol.
h.g.m.leufkens@uu.nl
Profiel
Publicaties
Activiteiten
Onderwijs
Nevenwerkzaamheden
Contact
Profiel
Publicaties
Activiteiten
Onderwijs
Nevenwerkzaamheden
Contact
Onderzoeksthema's
Institutions for Open Societies (IOS)
Life Sciences (LS)
Utrecht Advanced In Vitro Models Hub
Activiteiten
2010
Determinants of Safety Related Regulatory Actions of Biopharmaceuticals
Bert Leufkens
(Invited speaker)
3 Nov 2010
,
Poster presentation at ISoP Conference 2010
Drivers of Safety Related Regulatory Actions
Bert Leufkens
(Invited speaker)
4 Oct 2010
,
Poster presentation at FIGON Dutch Medicines Day (Lunteren, The Netherlands)
The contribution of Periodic Safety Update Reporting on Safety-Related Regulatory Actions
Bert Leufkens
(Invited speaker)
15 Apr 2010
,
Poster presentation at the TI Pharma Spring Meeting
Presentationa at Braunschweig conference: Drugs, Living things and the problems of Standardization
Bert Leufkens
(Invited speaker)
25 Mar 2010
The Impact of Periodic Safety Update Reporting on Safety-Related Regulatory Actions
Bert Leufkens
(Invited speaker)
7 Jan 2010
,
Presentation at WHO winter-meeting 2010
2006
Use of statins, risk of fracture and age-band bias
Bert Leufkens
(Invited speaker)
2006
Use of beta-2 agonists and risk of hip fracture
Bert Leufkens
(Invited speaker)
2006
Statin therapy and reduced risk of pneumonia in senior
Bert Leufkens
(Invited speaker)
2006
Patterns and continuation af asthma medication use in preschool children: results from the PIAMA-study
Bert Leufkens
(Invited speaker)
2006
Ace-inhibitor use and decreased pneumonia risk in elderly patients with diabetes
Bert Leufkens
(Invited speaker)
2006
2002
Tailormade pharmacotherapy: Future developments and ethical challenges in the field of pharmacogenomics
Bert Leufkens
(Contributor)
2002
→ …
,
De maatschappelijke component van het genomics-onderzoek